The agency says the company has reported 37 serious injuries and three deaths related to the issue as of August 17.
Boston Scientific has reported one serious injury, but no deaths, related to the defect. Today the FDA announced a Class I ...
While there’s no harm in discontinuing for patients who’ve yet to develop ASCVD by age 75, the trial also found no clear ...
There was a modest gain in the number of days alive and at home after the operation, with a significant savings in blood ...
A drop in hemoglobin isn’t cause to panic but may warrant action based on patient-specific factors, says Husam Abdel-Qadir.
This month: toilet seats to detect AF, respiratory protection from statins, video education for PCI discharge, and more.
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...
A post hoc analysis of 2-year TLF risk found few independent predictors. Only one was modifiable: percent diameter stenosis ...
An analysis of CDC data for 1999-2024 shows that patient prognosis varied by sex, age, race/ethnicity, and region.
Deliberate efforts are needed to change the situation, which hasn’t improved much since 2010, researchers say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results